Orchestra BioMed Holdings, Inc. SEC filings OBIO
Orchestra BioMed Holdings, Inc. has 412 filings in SEC EDGAR's recent list, going back to Jun 22, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 24, 2024 | — |
| CORRESP | Letter to the SEC | May 22, 2024 | — |
| UPLOAD | Letter from the SEC | May 20, 2024 | — |
| EFFECT | Filing | May 9, 2024 | — |
| CORRESP | Letter to the SEC | May 8, 2024 | — |
| CORRESP | Letter to the SEC | Apr 25, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 18, 2024 | — |
| CORRESP | Letter to the SEC | Mar 27, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 24, 2023 | — |
| 425 | Current report | Jan 25, 2023 | — |
| 425 | Form 425 | Jan 10, 2023 | — |
| EFFECT | Filing | Dec 16, 2022 | — |
| SEC STAFF LETTER | Filing | Dec 16, 2022 | — |
| CORRESP | Letter to the SEC | Dec 15, 2022 | — |
| CORRESP | Letter to the SEC | Dec 15, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2022 | — |
| CORRESP | Letter to the SEC | Dec 12, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 7, 2022 | — |
| 425 | Form 425 | Dec 1, 2022 | — |
| CORRESP | Letter to the SEC | Nov 21, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 9, 2022 | — |
| SEC STAFF LETTER | Filing | Oct 31, 2022 | — |
| CORRESP | Letter to the SEC | Oct 21, 2022 | — |
| 425 | Current report | Oct 21, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2022 | — |
| CORRESP | Letter to the SEC | Sep 23, 2022 | — |
| 425 | Form 425 | Sep 20, 2022 | — |
| 425 | Form 425 | Sep 20, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2022 | — |
| 425 | Filing | Jul 8, 2022 | — |
| 425 | Form 425 | Jul 5, 2022 | — |
| 425 | Filing | Jul 5, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 1, 2022 | — |
| CORRESP | Letter to the SEC | Jun 28, 2022 | — |
| PRER14A | Filing | Jun 28, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 27, 2022 | — |
| CERT | Filing | Aug 4, 2020 | — |
| EFFECT | Filing | Aug 3, 2020 | — |
| 8-A12B | Form 8-a12b | Aug 3, 2020 | — |
| CORRESP | Letter to the SEC | Jul 30, 2020 | — |
| CORRESP | Letter to the SEC | Jul 30, 2020 | — |
| DRS | Filing | Jun 22, 2020 | — |
Showing 42 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- OBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Hope, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1814114
- Former names
- Health Sciences Acquisitions Corp 2 (until Jan 26, 2023)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.